Huntington National Bank’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $446K | Buy |
1,988
+61
| +3% | +$15.2K | ﹤0.01% | 664 |
|
|
2025
Q4 | $464K | Buy |
1,927
+123
| +7% | +$31.5K | ﹤0.01% | 569 |
|
|
2025
Q3 | $494K | Sell |
1,804
-10
| -0.6% | -$2.73K | ﹤0.01% | 550 |
|
|
2025
Q2 | $468K | Sell |
1,814
-44
| -2% | -$10.5K | ﹤0.01% | 545 |
|
|
2025
Q1 | $416K | Sell |
1,858
-184
| -9% | -$43K | ﹤0.01% | 552 |
|
|
2024
Q4 | $467K | Buy |
2,042
+174
| +9% | +$41.9K | ﹤0.01% | 525 |
|
|
2024
Q3 | $456K | Buy |
1,868
+120
| +7% | +$26.8K | ﹤0.01% | 534 |
|
|
2024
Q2 | $335K | Buy |
1,748
+45
| +3% | +$9.13K | ﹤0.01% | 573 |
|
|
2024
Q1 | $337K | Sell |
1,703
-47
| -3% | -$8.61K | ﹤0.01% | 571 |
|
|
2023
Q4 | $301K | Buy |
1,750
+74
| +4% | +$11.4K | ﹤0.01% | 571 |
|
|
2023
Q3 | $248K | Buy |
1,676
+152
| +10% | +$27.5K | ﹤0.01% | 592 |
|
|
2023
Q2 | $333K | Buy |
1,524
+207
| +16% | +$46.1K | ﹤0.01% | 554 |
|
|
2023
Q1 | $288K | Sell |
1,317
-41
| -3% | -$8.89K | ﹤0.01% | 562 |
|
|
2022
Q4 | $283K | Buy |
1,358
+901
| +197% | +$198K | ﹤0.01% | 561 |
|
|
2022
Q3 | $100K | Sell |
457
-224
| -33% | -$51K | ﹤0.01% | 777 |
|
|
2022
Q2 | $143K | Sell |
681
-381
| -36% | -$81.1K | ﹤0.01% | 692 |
|
|
2022
Q1 | $258K | Buy |
1,062
+1
| +0.1% | +$242 | ﹤0.01% | 603 |
|
|
2021
Q4 | $276K | Buy |
1,061
+291
| +38% | +$75.5K | ﹤0.01% | 592 |
|
|
2021
Q3 | $203K | Buy |
770
+258
| +50% | +$70.5K | ﹤0.01% | 609 |
|
|
2021
Q2 | $126K | Buy |
512
+2
| +0.4% | +$420 | ﹤0.01% | 689 |
|
|
2021
Q1 | $99K | Buy |
510
+401
| +368% | +$80.4K | ﹤0.01% | 657 |
|
|
2020
Q4 | $23K | Buy |
109
+82
| +304% | +$16.4K | ﹤0.01% | 1080 |
|
|
2020
Q3 | $5K | Buy |
27
+10
| +59% | +$1.85K | ﹤0.01% | 1334 |
|
|
2020
Q2 | $3K | Sell |
17
-443
| -96% | -$72.5K | ﹤0.01% | 1386 |
|
|
2020
Q1 | $68K | Hold |
460
| – | – | ﹤0.01% | 696 |
|
|
2019
Q4 | $71K | Buy |
460
+366
| +389% | +$52.8K | ﹤0.01% | 815 |
|
|
2019
Q3 | $13K | Buy |
94
+77
| +453% | +$10.1K | ﹤0.01% | 1225 |
|
|
2019
Q2 | $2K | Hold |
17
| – | – | ﹤0.01% | 1510 |
|
|
2019
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 1490 |
|
|
2018
Q4 | $2K | Buy |
+17
| New | +$1.82K | ﹤0.01% | 1572 |
|
|
2017
Q3 | – | Sell |
-2,000
| Closed | -$156K | – | 1644 |
|
|
2017
Q2 | $156K | Buy |
+2,000
| New | +$143K | ﹤0.01% | 620 |
|
|
2016
Q2 | – | Sell |
-400
| Closed | -$29K | – | 1639 |
|
|
2016
Q1 | $29K | Buy |
+400
| New | +$22.6K | ﹤0.01% | 1266 |
|
|
2015
Q2 | – | Sell |
-400
| Closed | -$29K | – | 1820 |
|
|
2015
Q1 | $29K | Hold |
400
| – | – | ﹤0.01% | 1269 |
|
|
2014
Q4 | $22K | Buy |
+400
| New | +$20.9K | ﹤0.01% | 1330 |
|
|
2014
Q1 | – | Sell |
-400
| Closed | -$19K | – | 1453 |
|
|
2013
Q4 | $19K | Sell |
400
-150
| -27% | -$7.59K | ﹤0.01% | 1335 |
|
|
2013
Q3 | $29K | Buy |
550
+150
| +38% | +$7.28K | ﹤0.01% | 1224 |
|
|
2013
Q2 | $18K | Buy |
+400
| New | +$19K | ﹤0.01% | 1318 |
|
Other funds holding RMD
VCM
VPM
DAM
Huntington National Bank's RMD Position: Q1 2026 in Review
Huntington National Bank increased its ResMed (RMD) stake by 3.2% in Q1 2026, buying an estimated $15.2K and bringing the position to 1,988 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #664.
Huntington National Bank first reported a position in RMD in Q2 2013 and has held it in 37 quarters since. The position peaked at $494K in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Huntington National Bank held 1,988 shares of ResMed worth $446K as of Q1 2026.
- Huntington National Bank bought 61 ResMed shares in Q1 2026, an estimated $15.2K.
- ResMed made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #664 holding.
- Huntington National Bank first reported a position in ResMed in Q2 2013 and has held it in 37 quarters since.
- Huntington National Bank's ResMed position peaked at $494K in Q3 2025.
- 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.